Prostate cancer diagnostics in clinical practice is based on prostate-specific antigen PSA testing, rectal examination, transrectal ultrasound of the prostate gland and magnetic resonance imaging (MRI). This evidence concerns the gene KLK3 and prostate carcinoma.